Informações:
Falhas:
ID
32693
Descrição
Study ID: 107038 Clinical Study ID: LPL107038 Study Title: Study to Estimate the Dose Proportionality of the Enteric-Coated Freebase Formulation of SB-480848 Patient Level Data: Clinicaltrials.gov Identifier: Sponsor: GlaxoSmithKline Collaborators: N/A Phase: Phase 1 Study Recruitment Status: Completed Generic Name: darapladib Trade Name: Tyrisa ,US Study Indication: Atherosclerosis
Palavras-chave
Versões (1)
- 12/11/2018 12/11/2018 -
Titular dos direitos
GSK group of companies
Transferido a
12 de novembro de 2018
DOI
Para um pedido faça login.
Licença
Creative Commons BY-NC 3.0
Comentários do modelo :
Aqui pode comentar o modelo. Pode comentá-lo especificamente através dos balões de texto nos grupos de itens e itens.
Comentários do grupo de itens para :
Comentários do item para :
Para descarregar formulários, precisa de ter uma sessão iniciada. Por favor faça login ou registe-se gratuitamente.
Estimation of Dose Proportionality of Darapladib - 107038
Pharmacodynamics Post Dose Data - [Analyte and PD sample type]
- StudyEvent: ODM
Similar models
Pharmacodynamics Post Dose Data - [Analyte and PD sample type]
- StudyEvent: ODM
Name
Tipo
Description | Question | Decode (Coded Value)
Tipo de dados
Alias
Dosing date
Item
Dosing date
date
Dosing time
Item
Dosing time
time
Time of sample
Item
Time of sample
time
Time of sample
Item
Time of sample
time
Time of sample
Item
Time of sample
time
Time of sample
Item
Time of sample
time
Time of sample
Item
Time of sample
time
Time of sample
Item
Time of sample
time
Time of sample
Item
Time of sample
time
Time of sample
Item
Time of sample
time
Date of sample
Item
Date of sample
date
Time of sample
Item
Time of sample
time
Date of sample
Item
Date of sample
date
Time of sample
Item
Time of sample
time
Date of sample
Item
Date of sample
date
Time of sample
Item
Time of sample
time
Sem comentários